Pathstone Family Office’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$300K Buy
+4,460
New +$307K ﹤0.01% 1310
2022
Q4
– Sell
-5,063
Closed -$230K – 1328
2022
Q3
$230K Buy
+5,063
New +$253K ﹤0.01% 1047
2022
Q2
– Sell
-3,726
Closed -$212K – 1079
2022
Q1
$212K Buy
+3,726
New +$195K ﹤0.01% 877
2021
Q4
– Sell
-4,303
Closed -$258K – 917
2021
Q3
$258K Buy
4,303
+132
+3% +$8.3K 0.01% 720
2021
Q2
$260K Sell
4,171
-142
-3% -$9.46K 0.01% 691
2021
Q1
$282K Buy
4,313
+4,019
+1,367% +$262K 0.01% 501
2020
Q4
$19K Hold
294
– – ﹤0.01% 706
2020
Q3
$15K Hold
294
– – ﹤0.01% 534
2020
Q2
$14K Hold
294
– – ﹤0.01% 469
2020
Q1
$15K Buy
+294
New +$17K ﹤0.01% 450
2019
Q4
– Sell
-294
Closed -$15K – 482
2019
Q3
$15K Hold
294
– – ﹤0.01% 439
2019
Q2
$15K Hold
294
– – ﹤0.01% 481
2019
Q1
$14K Buy
+294
New +$14.9K ﹤0.01% 471

Other funds holding EHC

Pathstone Family Office's EHC Position: Q3 2023 in Review

Pathstone Family Office opened a new position in Encompass Health (EHC) in Q3 2023: 4,460 shares worth $300K. The stake represents ﹤0.01% of the portfolio and ranks #1310 among its holdings. This is a return to the name: Pathstone Family Office previously reported a position in EHC as recently as Q3 2022.

Pathstone Family Office first reported a position in EHC in Q1 2019 and has held it in 13 quarters since. 412 funds tracked by Wall St. Rank hold EHC as of Q3 2023.

  • Pathstone Family Office held 4,460 shares of Encompass Health worth $300K as of Q3 2023.
  • Encompass Health was a new Pathstone Family Office position in Q3 2023.
  • Encompass Health made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1310 holding.
  • Pathstone Family Office first reported a position in Encompass Health in Q1 2019 and has held it in 13 quarters since.
  • 412 funds tracked by Wall St. Rank held Encompass Health as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.